Table 2. Description of the controlled clinical trials included in the study.
Author | Year | Country | Location | Age in years | # of Subjects | Leishmania species |
---|---|---|---|---|---|---|
Navin T [33] | 1990 | Guatemala | Soldiers | 18–60 | T a = 22 G b = 22 | L. (V) braziliensis L. (L) mexicana |
Reithinger R [43] | 2005 | Afghanistan | HealthNet International Khair Khana clinic | T a = 108 G b = 151 | L. (L) tropica | |
Lobo I [40] | 2006 | Brazil | Bay Clinic | ≥18 | T a = 16 G b = 20 | L. (V) braziliensis |
Sadeghian G [44] | 2007 | Iran | Research Center for Skin Diseases and Leishmaniasis | ≥5 | T a = 57 G b = 60 | No data |
Aronson N [38] | 2010 | United States | Soldiers | ≥18 | T a = 25 G b = 2 | L. (L) major |
Safi N [45] | 2012 | Afghanistan | National Malaria and Leishmaniasis Control Program | ≥4 | T a = 195 G b = 195 | L. (L) tropica |
López L [20] | 2012 | Colombia | Soldiers | ≥18 | T a = 149 G b = 143 | L. (V) panamensis, L. (V) braziliensis |
Bumb R [39] | 2013 | India | Dermatology Center | ≥ 5 | T a = 50 G b = 50 | L. (L) tropica |
aT = Thermotherapy.
bG = Glucantime.